Qifu Li Selected Research

Small Interfering RNA (siRNA)

12/2021	HDAC9 in the Injury of Vascular Endothelial Cell Mediated by P38 MAPK Pathway.
1/2021	G Protein-Coupled Estrogen Receptor 1 (GPER1) Mediates Aldosterone-Induced Endothelial Inflammation in a Mineralocorticoid Receptor-Independent Manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qifu Li Research Topics

Disease

28	Hyperaldosteronism (Conn Syndrome) 12/2024 - 01/2016
22	Type 2 Diabetes Mellitus (MODY) 01/2023 - 04/2012
17	Insulin Resistance 01/2021 - 01/2011
15	Inflammation (Inflammations) 02/2023 - 06/2011
12	Neoplasms (Cancer) 11/2023 - 05/2005
12	Obesity 07/2023 - 01/2013
9	Epilepsy (Aura) 01/2021 - 07/2009
7	Non-alcoholic Fatty Liver Disease 10/2020 - 01/2014
6	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 07/2014
6	Stroke (Strokes) 01/2024 - 10/2008
6	Hypertension (High Blood Pressure) 01/2023 - 06/2013
5	Cognitive Dysfunction 05/2024 - 01/2021
5	Ischemic Stroke 12/2023 - 10/2008
5	Adenoma (Adenomas) 08/2023 - 01/2019
5	Body Weight (Weight, Body) 01/2023 - 08/2017
5	Chronic Renal Insufficiency 01/2023 - 12/2015
4	Idiopathic Generalized Epilepsy 02/2024 - 06/2012
4	Seizures (Absence Seizure) 12/2022 - 07/2009
4	Essential Hypertension 01/2022 - 01/2016
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 12/2015
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 08/2012 - 03/2011
3	Sarcopenia 01/2023 - 01/2017
3	Osteoporosis 01/2023 - 04/2020
3	Weight Loss (Weight Reduction) 10/2022 - 05/2017
3	Albuminuria 01/2022 - 02/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2018
3	Hyperglycemia 01/2022 - 03/2015
3	Postmenopausal Osteoporosis 04/2020 - 01/2018
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 12/2010
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2016
3	Hyperuricemia 01/2019 - 02/2013
3	Hypoglycemia (Reactive Hypoglycemia) 07/2014 - 10/2008
3	Herpes Zoster 02/2014 - 04/2009
3	Postherpetic Neuralgia 02/2014 - 04/2009
2	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2020
2	Iron Overload 11/2023 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 11/2020
2	Abdominal Obesity 07/2023 - 01/2023
2	Pain (Aches) 02/2023 - 01/2023
2	Mental Disorders (Mental Disorder) 01/2023 - 01/2019
2	Schizophrenia (Dementia Praecox) 01/2023 - 01/2022
2	Pheochromocytoma 10/2022 - 03/2018
2	Multiple Sclerosis 05/2021 - 05/2021

Drug/Important Bio-Agent (IBA)

22	AldosteroneIBA 12/2024 - 01/2016
14	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2012
11	Insulin (Novolin)FDA Link 01/2023 - 10/2008
9	ReninIBA 12/2024 - 07/2016
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2005
7	bisphenol AIBA 02/2019 - 12/2015
6	Captopril (Capoten)FDA LinkGeneric 01/2024 - 01/2019
6	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2023 - 10/2008
6	CreatinineIBA 01/2023 - 12/2015
6	LipidsIBA 01/2021 - 06/2011
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2013
5	Immunoglobulin E (IgE)IBA 02/2024 - 05/2012
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 04/2012
5	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
5	C-Reactive ProteinIBA 01/2020 - 01/2011
4	oxidized low density lipoproteinIBA 04/2024 - 06/2013
4	Messenger RNA (mRNA)IBA 02/2023 - 10/2008
4	Insulin Glargine (Lantus)FDA Link 01/2022 - 04/2012
4	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2018
4	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 07/2016
3	EnzymesIBA 02/2023 - 01/2016
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 08/2012
3	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2022 - 11/2018
3	PotassiumIBA 01/2022 - 01/2020
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 12/2021 - 10/2008
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 01/2018
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 09/2015
3	CholesterolIBA 01/2020 - 06/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019 - 06/2015
3	Uric Acid (Urate)IBA 01/2019 - 02/2013
3	Cystatin CIBA 02/2016 - 12/2015
3	pigment epithelium-derived factorIBA 03/2014 - 03/2011
2	Peptides (Polypeptides)IBA 05/2024 - 05/2005
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2024 - 12/2023
2	Hormones (Hormone)IBA 11/2023 - 10/2008
2	AntioxidantsIBA 02/2023 - 07/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 07/2014
2	Teriparatide (Parathar)FDA Link 01/2022 - 11/2018
2	Parathyroid Hormone (Parathormone)IBA 01/2022 - 04/2020
2	SodiumIBA 12/2021 - 01/2019
2	Small Interfering RNA (siRNA)IBA 12/2021 - 01/2021
2	AlbuminsIBA 10/2021 - 01/2018
2	Sphingosine-1-Phosphate ReceptorsIBA 05/2021 - 05/2021

Therapy/Procedure

14	Therapeutics 11/2023 - 03/2015
6	Glycemic Control 01/2022 - 10/2008
4	Acupuncture Points (Acupuncture Point) 07/2023 - 01/2023
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 07/2009
3	Drug Therapy (Chemotherapy) 11/2023 - 12/2021
3	Bariatric Surgery 07/2023 - 05/2017
3	Adrenalectomy 01/2023 - 12/2020
3	Precision Medicine 01/2017 - 01/2016
2	Surgical Amputation (Amputations) 12/2023 - 01/2017
2	Catgut 07/2023 - 01/2023
2	Acupuncture Therapy 07/2023 - 02/2023
2	Aftercare (After-Treatment) 01/2023 - 04/2020